L9LS MAb in Malian Adults

Clinical trial NCT05816330 · COMPLETED

Trial details

NCT number: NCT05816330
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmodium Falciparum Infection Malaria

Start date: 2023-05-25
Primary completion: 2024-02-11
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.